99 related articles for article (PubMed ID: 1373064)
1. Effect of isoprinosine on HIV antigenaemia.
Teglbjaerg LL; Kroon S; Sandström E; Moestrup T; Hansson BG; Vestergaard BF
AIDS; 1992 Feb; 6(2):199-201. PubMed ID: 1373064
[TBL] [Abstract][Full Text] [Related]
2. Neopterin and beta 2-microglobulin as serum markers in a placebo-controlled anti-HIV therapy trial.
Carstens J; Teglbjaerg LS; Black FT
Eur J Clin Chem Clin Biochem; 1995 Sep; 33(9):559-62. PubMed ID: 8611664
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO
N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173
[TBL] [Abstract][Full Text] [Related]
4. One-year follow-up on the safety and efficacy of isoprinosine for human immunodeficiency virus infection. Scandinavian Isoprinosine Study Group.
Thorsen S; Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO
J Intern Med; 1992 Jun; 231(6):607-15. PubMed ID: 1377741
[TBL] [Abstract][Full Text] [Related]
5. [Controlled, clinical trial of isoprinosine administration to HIV-infected patients. Results of a Danish/Swedish multicenter study. The Scandinavian Isoprinosine Study Group].
Thorsen S; Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO
Ugeskr Laeger; 1994 May; 156(22):3314-8. PubMed ID: 7520643
[TBL] [Abstract][Full Text] [Related]
6. Immunorestorative properties of isoprinosine in the treatment of patients at high risk of developing ARC or AIDS.
Bekesi JG; Tsang PH; Wallace JI; Roboz JP
J Clin Lab Immunol; 1987 Dec; 24(4):155-61. PubMed ID: 2452254
[TBL] [Abstract][Full Text] [Related]
7. [Promising results of a Danish-Swedish clinical trial: isoprinosine administered to HIV positive patients prevented development of AIDS].
Lennholm B
Lakartidningen; 1990 Jun; 87(26-27):2253. PubMed ID: 1694549
[No Abstract] [Full Text] [Related]
8. [A warning against exaggerated optimism about isoprinosine in HIV infection].
Norrby R
Lakartidningen; 1990 Aug; 87(32-33):2487-8. PubMed ID: 1697923
[No Abstract] [Full Text] [Related]
9. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE
AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778
[TBL] [Abstract][Full Text] [Related]
10. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
Mulder JW; Cooper DA; Mathiesen L; Sandström E; Clumeck N; Gatell JM; French M; Donovan B; Gray F; Yeo JM
AIDS; 1994 Mar; 8(3):313-21. PubMed ID: 7913326
[TBL] [Abstract][Full Text] [Related]
11. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
[TBL] [Abstract][Full Text] [Related]
12. [Isoprinosine therapy in chronic hepatitis C (multicenter placebo-controlled double-blind prospective study)].
Pár A; Beró T; Brasch G; Gógl A; Kamarás G; Méhesfalvi E; Ozsvár Z; Paál M; Szipöcs I; Telegdy L
Orv Hetil; 1993 May; 134(19):1015-9. PubMed ID: 7684118
[TBL] [Abstract][Full Text] [Related]
13. Anti-p24 antibody reactivity in the acquired immunodeficiency syndrome (AIDS)-related complex treated with isoprinosine.
Tsang KY; Johnson EA; La Via MF
Ann Intern Med; 1988 Oct; 109(7):595. PubMed ID: 2458693
[No Abstract] [Full Text] [Related]
14. Clinical, virologic, and immunologic effects of combination therapy with ribavirin and isoprinosine in HIV-infected homosexual men.
Schulof RS; Parenti DM; Simon GL; Paxton H; Meyer WA; Schlesselman SB; Courtless J; LeLacheur S; Sztein MB
J Acquir Immune Defic Syndr (1988); 1990; 3(5):485-92. PubMed ID: 1691287
[TBL] [Abstract][Full Text] [Related]
15. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study.
Beran J; Šalapová E; Špajdel M;
BMC Infect Dis; 2016 Nov; 16(1):648. PubMed ID: 27821093
[TBL] [Abstract][Full Text] [Related]
16. Isoprinosine and Imuthiol, two potentially active compounds in patients with AIDS-related complex symptoms.
Pompidou A; Delsaux MC; Telvi L; Mace B; Coutance F; Falkenrodt A; Lang JM
Cancer Res; 1985 Sep; 45(9 Suppl):4671s-4673s. PubMed ID: 2410111
[TBL] [Abstract][Full Text] [Related]
17. Effects of isoprinosine treatment of HIV-positive patients on blood mononuclear cell subsets, NK- and T-cell function, tumour necrosis factor, and interleukins 1, 2, and 6.
Pedersen BK; Tvede N; Diamant M; Gerstoft J; Bagge Hansen M; Haahr PM; Hørding M; Kappel M; Klokker M; Søeberg B
Scand J Immunol; 1990 Dec; 32(6):641-9. PubMed ID: 1702899
[TBL] [Abstract][Full Text] [Related]
18. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of isoprinosine in genetically susceptible BALB/c mice infected with Leishmania major.
Cillari E; Dieli M; Lo Campo P; Sireci G; Caffarelli A; Maltese E; Millott S; Milano S; Liew FY
Immunology; 1991 Sep; 74(1):25-30. PubMed ID: 1718853
[TBL] [Abstract][Full Text] [Related]
20. Isoprinosine does not protect against frequent respiratory tract infections in childhood.
Litzman J; Lokaj J; Krejcí M; Pesák S; Morgan G
Eur J Pediatr; 1999 Jan; 158(1):32-7. PubMed ID: 9950305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
